Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 166.82

+0.2%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cheryl Galt who wrote (229)	5/22/2000 3:08:00 PM
From: scaram(o)uche	Read Replies (1) of 395

Cheryl: No, not really. However, I feel, still, that RGEN's management is sincere. I like these guys. That said, I was always (see thread) hesitant to believe in their approach to angiogenesis, and did not appreciate the way that they just quietly switched to autism and let angio slip away. No guts. Jim Silverman always had a bead on that issue. He just flat out said that they didn't have the resources to get it done. But, net-net, I like them. If you call and talk to Dan Witt, I think that you'll get a biased but clear view of what they're doing. I'm focused on other stuff, but CTLA-4 could pull me back quickly. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next